Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

5 Jun 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to CRISPR and Genetic Engineering

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 28607484
DOI: 10.1038/nature22794

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistancePMID 28607484Read ↗

Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistanceSemantic proximity Read ↗

Drug Resistance in Cancers: A Free Pass for BullyingSemantic proximity Read ↗

Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.Semantic proximity Read ↗

Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapySemantic proximity Read ↗

Cancer as a reprogramming-like disease: Implications in tumor development and treatmentSemantic proximity Read ↗

Nonheritable cellular variability accelerates the evolutionary processes of cancer.Semantic proximity Read ↗

The cellular origins of drug resistance in cancer.Semantic proximity Read ↗

Shaping of tumor and drug-resistant genomes by instability and selectionSemantic proximity Read ↗

In cancer drug resistance, germline matters tooSemantic proximity Read ↗

Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging TreatmentsSemantic proximity Read ↗

Genetic and non‐genetic drug resistance: Darwin or Lamarck?Semantic proximity Read ↗

Drug resistance, epigenetics, and tumor cell heterogeneity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.